Resultados de la búsqueda 221-230 of 5442 for pharmacogenetics

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...

  2. Mayo Clinic PM&R Physician Update - October 2025

    Page 1.

  3. Mayo Clinic PM&R Physician Update - June 2025

    Page 1.

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  5. Mayo Clinic Ophthalmology Physician Update - August 2023

    Page 1.

  6. Mayo Clinic Physician Update - July 2022

    Page 1.

  7. Mayo Clinic PM&R Physician Update - February 2025

    Page 1.

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate olaparib and temozolomide in treating patients with uterine leiomyosarcoma (LMS) that has spread to other places of ...

  9. Mayo Clinic PM&R Physician Update - June 2023

    Page 1.

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work in ...